NCT01762670View on ClinicalTrials.gov

GoldenCareTM for the Treatment of Bacterial Vaginosis

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Bacterial Vaginosis
Interventions
DRUG

GoldenCare

Copper intravaginal device to treat bacterial vaginosis.

DRUG

Metronidazole

500 mg twice daily for 7 days

Trial Locations (2)

19140

Temple University Hospital Department of OB/GYN, Philadelphia

48201

Harper University Hospital Department of Infectious Diseases, Detroit

Sponsors
All Listed Sponsors
lead

CDA Research Group, Inc.

INDUSTRY